Kronox Lab Sciences Limited has submitted its quarterly compliance certificate to stock exchanges, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018. The submission was made on April 3, 2026, covering the quarter ended March 31, 2026.

Regulatory Compliance Submission

The company submitted the Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 to both the National Stock Exchange of India Limited and BSE Limited. This certificate is a mandatory quarterly submission that ensures transparency in securities transactions and dematerialization processes.

Certificate Issuer and Verification

The certificate was issued by KFin Technologies Limited, which serves as the Registrar and Share Transfer Agent for Kronox Lab Sciences Limited. Sharmila Hemant Amin, Assistant Vice President at KFin Technologies Limited, signed the certificates on April 1, 2026.

The certificate confirms that details of securities dematerialized and rematerialized during the quarter ended March 31, 2026, have been properly furnished to all stock exchanges where the company's shares are listed, as required under the SEBI regulations.

Corporate Information

Kronox Lab Sciences Limited operates from its corporate office located at Block No. 284, Village Dabhasa, Taluka Padra, District Vadodara, Gujarat State. The company's registered office is situated at Block No. 353, Village Ekalbara, Taluka Padra, District Vadodara, Gujarat State.

Compliance Officer Details

Nikhil Goswami, Company Secretary and Compliance Officer with Membership No. A68272, signed the submission letter on behalf of Kronox Lab Sciences Limited. The digital signature was applied on April 3, 2026, at 13:15:33 +05'30'.

This quarterly submission demonstrates the company's commitment to maintaining regulatory compliance and transparency in its securities operations, ensuring all stakeholders have access to accurate information regarding share transactions and dematerialization activities.

KRONOX Lab Sciences Limited has announced the publication of its unaudited financial results for the quarter and nine months ended December 31, 2025. The pharmaceutical company has completed its regulatory disclosure requirements following the approval of these results by its Board of Directors.

Board Approval and Regulatory Compliance

The Board of Directors of KRONOX Lab Sciences Limited approved the unaudited standalone financial results at their meeting held on February 14, 2026. This approval came based on recommendations from the company's Audit Committee, ensuring proper governance oversight of the financial reporting process.

Newspaper Publication Requirements

Pursuant to Regulation 47 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, the company published its financial results in designated newspapers. The results appeared in Indian Express (English) and Financial Express (Gujarati) on February 16, 2026, ensuring compliance with multilingual publication requirements.

Result Accessibility

The company has made the unaudited financial results readily accessible through multiple channels:

• Company website at https://www.kronoxlabsciences.com/investors/quarterly-results/
• Quick Response (QR) code for digital access
• Stock exchange websites as per regulatory requirements

Corporate Information

KRONOX Lab Sciences Limited operates from its registered office located at Block No. 353, Village: Ekalbara, Taluka: Padra, District: Vadodara - 391440, Gujarat. The company maintains its corporate office at Block No. 284, Village: Dabhasa, Taluka: Padra, District: Vadodara, Gujarat State - 391440.

The announcement was signed by Ketan Ramani, Whole-time Director (DIN: 01510833), and Nikhil Goswami, Company Secretary & Compliance Officer (Membership No. A68272), demonstrating proper corporate authorization and compliance oversight.